rdf:type |
|
lifeskim:mentions |
umls-concept:C0002198,
umls-concept:C0016016,
umls-concept:C0026809,
umls-concept:C0032144,
umls-concept:C0038418,
umls-concept:C0311402,
umls-concept:C0439855,
umls-concept:C0443286,
umls-concept:C1515655,
umls-concept:C1704259,
umls-concept:C1705987
|
pubmed:issue |
2
|
pubmed:dateCreated |
1982-9-10
|
pubmed:abstractText |
The catabolic pathways of streptokinase, plasmin, and activator complex prepared with human plasminogen were studied in mice. (125)I-streptokinase clearance occurred in the liver and was 50% complete in 15 min. Incubation with mouse plasma had no effect on the streptokinase clearance rate. Complexes of plasmin and alpha(2)-plasmin inhibitor were eliminated from the plasma by a specific and saturable pathway. Competition experiments demonstrated that this pathway is responsible for the clearance of injected plasmin. Streptokinase-plasminogen activator complex formed with either (125)I-plasminogen or (125)I-streptokinase cleared in the liver at a significantly faster rate than either of the uncomplexed proteins (50% clearance in <3 min). Streptokinase incubated with human plasma also demonstrated this accelerated clearance. p-Nitrophenyl-p'-guanidinobenzoate-HCl or pancreatic trypsin inhibitor-treated complex cleared slowly compared with untreated complex independent of which protein was radiolabeled. Significant competition for clearance was demonstrated between alpha(2)-macroglobulin-trypsin and activator complex only when the plasmin(ogen) was the radiolabeled moiety. Large molar excesses of alpha(2)-plasmin inhibitor-plasmin failed to retard the clearance of activator complex. Hepatic binding of streptokinase-plasmin, in liver perfusion experiments, was dependent upon prior incubation with plasma (8-10% uptake compared to a background of approximately 2.5%). Substitution of human alpha(2)-macroglobulin for plasma also resulted in binding when the incubation was performed for 10 min at 37 degrees C (7.5%). Electrophoresis experiments confirmed the transfer of 0.8 mol plasmin/mol alpha(2)-macroglobulin when activator complex was incubated at 37 degrees C with alpha(2)-macroglobulin for 40 min. Streptokinase transfer from activator complex to alpha(2)-macroglobulin was negligible. The in vivo clearance of activator complex is proposed to involve active attack of the complex on the alpha(2)-macroglobulin "bait region," resulting in facilitated plasmin transfer. Dissociated streptokinase is rapidly bound and cleared by sites in the liver.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-1110418,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-1114491,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-132442,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-134998,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-13603526,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-137718,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-137901,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-13863764,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-13956267,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-14407413,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-146709,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-147769,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-158022,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-158524,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-16496527,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-16695653,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-36165,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-4201304,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-4254608,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-4258976,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-4269559,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-4272770,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-4360349,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-4846746,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-4981635,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-5044515,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-5475635,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-5552799,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6024301,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6154981,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6155149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6166634,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6167573,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6168492,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6172155,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6178438,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6204637,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-6255009,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-70499,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-7061476,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-7375938,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-77050,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-80217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-851219,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-88449,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-89116,
http://linkedlifedata.com/resource/pubmed/commentcorrection/6178757-91367
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0021-9738
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
412-23
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:6178757-Animals,
pubmed-meshheading:6178757-Drug Synergism,
pubmed-meshheading:6178757-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:6178757-Fibrinolysin,
pubmed-meshheading:6178757-Liver,
pubmed-meshheading:6178757-Metabolic Clearance Rate,
pubmed-meshheading:6178757-Mice,
pubmed-meshheading:6178757-Perfusion,
pubmed-meshheading:6178757-Plasminogen Activators,
pubmed-meshheading:6178757-Streptokinase,
pubmed-meshheading:6178757-Time Factors,
pubmed-meshheading:6178757-Tissue Distribution,
pubmed-meshheading:6178757-alpha-2-Antiplasmin,
pubmed-meshheading:6178757-alpha-Macroglobulins
|
pubmed:year |
1982
|
pubmed:articleTitle |
Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
|
pubmed:publicationType |
Journal Article
|